Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5- fluorouracil (5-FU)

John Nemunaitis, John Cox, Wally Meyer, Alice Courtney, Gabriele Mues

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5- fluorouracil (5-FU)'. Together they form a unique fingerprint.

Medicine & Life Sciences